MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Contribution of blood lipid profile to long-term outcome in idiopathic normal pressure hydrocephalus

J. Bissacco, D. Mascioli, C. Simonetta, M. Mancini, V. Buttarazzi, M. Conti, F. Veltri, S. Bagetta, M. Pierantozzi, A. Stefani, F. Buttari, D. Centonze, A. Pesce, M. Pieri, S. Borrelli, F. Di Giuliano, T. Schirinzi (Pozzilli, Italy)

Meeting: 2026 International Congress

Keywords: Lipid metabolism, Magnetic resonance imaging(MRI), Parkinsonism

Category: Parkinsonism (Other)

Objective: Here, we outlined the blood lipid profile, including derived indices of metabolic dyshomeostasis, in iNPH patients, and investigated relationships with brain MRI-based pathology markers, and long-term clinical outcomes.

Background: Idiopathic normal pressure hydrocephalus (iNPH) has a multifactorial pathogenesis[1] in which blood lipids may be theoretically involved, although in vivo evidence is lacking.

Method: We conducted a dual-center longitudinal study included 67 iNPH patients[table1]. At baseline, patients were assessed with the iNPH Grading Scale and the Modified Rankin Scale (mRS), the measurement of serum triglycerides (TG), total cholesterol, high-density lipoprotein (HDL), non-HDL, both the TG/HDL and neutrophil/HDL (NHR) ratios, the brain MRI-based evaluation of ventricular size and enlarged perivascular spaces (EPVS), and the APOE genotype. Depending on the five-year mRS score, patients were stratified per outcome[table2]. A control group of 38 controls was also enrolled[table1]. Variables were compared with ANCOVA, correlations tested, and ROC analysis.

Results: iNPH patients had TG, TG/HDL and NHR higher, and HDL lower than controls[figure1]. Among lipid level abnormalities, the increased TG/HDL ratio was the index most significantly associated with greater enlargement of centrum semiovale-EPVS at baseline (p = 0.012)[figure2], and worse long-term outcome at 5 years (AUC 0.81; cut-off value 2.40: 80% sensitivity, 67% specificity)[figure3]. Findings were independent of APOE genotype.

Conclusion: iNPH exhibit a characteristic lipid profile consistent with metabolic dysregulation and insulin resistance. Lipid levels and the TG/HDL index specifically may possibly reflect glymphatic dysfunction and predict the long-term outcome, emerging as an accessible readout of a complex pathogenic framework useful for patient stratification.

Table 1

Table 1

Table 2

Table 2

Figure 1

Figure 1

Figure 2

Figure 2

Figure 3

Figure 3

References: 1. Bonney PA, Briggs RG, Wu K, et al (2022) Pathophysiological Mechanisms Underlying Idiopathic Normal Pressure Hydrocephalus: A Review of Recent Insights. Front. Aging Neurosci. 14

To cite this abstract in AMA style:

J. Bissacco, D. Mascioli, C. Simonetta, M. Mancini, V. Buttarazzi, M. Conti, F. Veltri, S. Bagetta, M. Pierantozzi, A. Stefani, F. Buttari, D. Centonze, A. Pesce, M. Pieri, S. Borrelli, F. Di Giuliano, T. Schirinzi. Contribution of blood lipid profile to long-term outcome in idiopathic normal pressure hydrocephalus [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/contribution-of-blood-lipid-profile-to-long-term-outcome-in-idiopathic-normal-pressure-hydrocephalus/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/contribution-of-blood-lipid-profile-to-long-term-outcome-in-idiopathic-normal-pressure-hydrocephalus/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley